CIS-DIAMMINEDICHLOROPLATINUM(II)-DNA ADDUCT FORMATION IN RENAL, GONADAL, AND TUMOR-TISSUES OF MALE AND FEMALE RATS
- 1 February 1987
- journal article
- research article
- Vol. 47 (3) , 718-722
Abstract
Cis-Diamminedichloroplatinum(II) (cisplatin), a potent anticancer agent, is thought to exert its cytotoxic effects through DNA damage. Using a polyclonal rabbit antisera which recognizes intrastrand bidentate deoxy(ApG)- and deoxy(GpG)-N7-diammineplatinum adducts, an enzyme-linked immunosorbent assay has developed to quantitate this adduct in cisplatin-exposed DNA. Cisplatin-DNA adducts were measured in renal, gonadal, and tumor (sarcoma) tissues of Sprague-Dawley rats following i.v. or i.p. administration of cisplatin. When drug was administered i.v. to animals fed ad libitum adduct levels were highest in kidneys, 50% lower in s.c. sarcoma, and substantially lower in gonads. Under these experimental conditions, a large interindividual variability in adduct formation was observed in renal and tumor tissues, and adduct levels in some samples were too low to measure. Higher values among individuals were obtained using tissues of animals fasted overnight and treated i.p. Adduct levels following i.p. injections of drug were higher in kidneys and gonads of male rats than in kidneys and gonads of female rats. Analysis of tissue platinum content demonstrated higher platinum levels in kidneys of male rats than in kidneys of female rats, but the magnitude of this gender difference in total tissue platinum was not as great as that observed for adduct formation. When the influence of castration on adduct formation was investigated, adduct levels in kidneys of castrated females were higher than those in sham-operated females, but adduct levels in kidneys of the castrated male animals were not substantively different from those seen in sham-operated male controls. We conclude that the route of drug administration, diet, and hormonal status of the animal are factors that may influence cisplatin-DNA adduct formation in the rat.This publication has 8 references indexed in Scilit:
- Quantitation of cis-diamminedichloroplatinum II (cisplatin)-DNA-intrastrand adducts in testicular and ovarian cancer patients receiving cisplatin chemotherapy.Journal of Clinical Investigation, 1986
- The quantitative detection of various Pt-DNA-adducts in Chinese hamster ovary cells treated with cisplatin: application of immunochemical techniquesCarcinogenesis: Integrative Cancer Research, 1985
- High-Dose Cisplatin in Hypertonic SalineAnnals of Internal Medicine, 1984
- INDUCTION AND REPAIR OF DNA CROSS-LINKS IN CHINESE-HAMSTER OVARY CELLS TREATED WITH VARIOUS PLATINUM COORDINATION-COMPOUNDS IN RELATION TO PLATINUM BINDING TO DNA, CYTO-TOXICITY, MUTAGENICITY, AND ANTITUMOR-ACTIVITY1984
- Effect of probenecid and N′-methylnicotinamide on renal handling of cis-dichlorodiammineplatinum-II in ratsCancer Letters, 1983
- Antibodies elicited against cis-diamminedichloroplatinum(II)-modified DNA are specific for cis-diamminedichloroplatinum(II)-DNA adducts formed in vivo and in vitro.Proceedings of the National Academy of Sciences, 1982
- DNA-PROTEIN AND DNA INTERSTRAND CROSS-LINKING BY CIS-PLATINUM(II) AND TRANS-PLATINUM(II) DIAMMINEDICHLORIDE IN L1210 MOUSE LEUKEMIA-CELLS AND RELATION TO CYTOTOXICITY1979
- Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular CancerAnnals of Internal Medicine, 1977